Novelix Pharmaceuticals Ltd — Board Meeting, 20-05-2025: Board Meeting

Novelix Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and year ended March 31, 2025. The board will also finalize the appointment of the internal auditor for FY 2025-26 and the secretarial auditor for the next five years. Trading by designated persons and their immediate relatives will remain closed until 48 hours after the meeting, ensuring compliance with insider trading policies. These decisions will impact financial transparency and governance, strengthening oversight for shareholders.